1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Male Hypogonadism Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Male Hypogonadism Clinical Trials by Region
2.2.2 Average Enrollment of Male Hypogonadism Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Male Hypogonadism Treatment, 2019

3. Region wise Male Hypogonadism Clinical Trials
3.1 Asia Pacific Male Hypogonadism Clinical Trials by Country
3.2 Europe Male Hypogonadism Clinical Trials by Country
3.3 North America Male Hypogonadism Clinical Trials by Country
3.4 Middle East and Africa Male Hypogonadism Clinical Trials by Country
3.5 South and Central America Male Hypogonadism Clinical Trials by Country

4. Male Hypogonadism Clinical Trial Trends
4.1 Start Year wise Male Hypogonadism Clinical Trials
4.2 Phase wise Male Hypogonadism Clinical Trials
4.3 Trial Status wise Male Hypogonadism Clinical Trials
4.4 Trial Type wise Male Hypogonadism Clinical Trials

5. Male Hypogonadism Average Enrollment Trends
5.1 Average Enrollment in Male Hypogonadism Trials by Year
5.2 Average Enrollment in Male Hypogonadism Trials by Phase
5.3 Average Enrollment in Male Hypogonadism Trials by Status
5.4 Average Enrollment in Male Hypogonadism Trials by Type of Trial

6. Companies Participating in Male Hypogonadism Clinical Trials
6.1 Male Hypogonadism Trials by Sponsor Type
6.2 Male Hypogonadism Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Male Hypogonadism Trials- Phase 1
7.2 Male Hypogonadism Trials- Phase 2
7.3 Male Hypogonadism Trials- Phase 3
7.4 Male Hypogonadism Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Male Hypogonadism Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Male Hypogonadism Clinical Trials and Enrolment
Figure 5: Europe - Country wise Male Hypogonadism Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Male Hypogonadism Clinical Trials and Enrolment
Figure 7: North America - Country wise Male Hypogonadism Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Male Hypogonadism Clinical Trials and Enrolment
Figure 9: Male Hypogonadism Clinical Trials by Phase
Figure 10: Male Hypogonadism Clinical Trials by Trial Status
Figure 11: Male Hypogonadism Clinical Trials by Type
Figure 12: Male Hypogonadism Clinical Trials by Sponsor Type
Figure 13: Male Hypogonadism Clinical Trials by Leading Sponsors
Figure 14: Male Hypogonadism Average Enrollment by Phase
Figure 15: Male Hypogonadism Average Enrollment by Trial Status
Figure 16: Male Hypogonadism Average Enrollment by Type
Figure 17: Male Hypogonadism- Average Enrolment by Type of Sponsors
Figure 18: Male Hypogonadism- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Male Hypogonadism Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Male Hypogonadism Clinical Trials and Enrolment
Table 5: Europe - Country wise Male Hypogonadism Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Male Hypogonadism Clinical Trials and Enrolment
Table 7: North America - Country wise Male Hypogonadism Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Male Hypogonadism Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Male Hypogonadism Average Enrollment by Phase
Table 15: Male Hypogonadism Average Enrollment by Trial Status
Table 16: Male Hypogonadism Average Enrollment by Type
Table 17: Male Hypogonadism- Average Enrolment by Type of Sponsors
Table 18: Male Hypogonadism- Enrolment by Leading Sponsors

Companies mentioned
Abbott Laboratories, AbbVie Inc, Acerus Pharmaceuticals Corp, Bayer AG, Clarus Therapeutics Inc, Eli Lilly and Co, Endo International Plc, Ferring Holding SA, Merck & Co Inc, Repros Therapeutics Inc